Optomechanical drug delivery across the blood-brain barrier

Overview

The proposed solution introduces an innovative optomechanical platform designed to revolutionize drug delivery across the blood-brain barrier (BBB). By employing light-induced mechanical forces, this technology aims to temporarily alter BBB permeability, allowing non-invasive and targeted delivery of therapeutic agents into the brain. This advancement holds significant potential to enhance the treatment of central nervous system (CNS) disorders by improving drug efficacy and precision, thereby addressing one of the most challenging barriers in medical treatment.

Technical specifications

Key features:

• Integration of focused light sources, such as lasers, with precision actuators to induce localized mechanical vibrations
• Use of biocompatible materials to ensure safe interaction with biological tissues
• Implementation of advanced imaging techniques, including MRI and confocal microscopy, to monitor BBB opening and drug distribution
• Preclinical validation using small-animal models to test BBB modulation and drug delivery efficacy

Applications:

• Non-invasive treatment of neurological diseases through targeted drug delivery
• Potential for use in a wide range of CNS disorders, improving patient outcomes with minimal invasiveness

Technology readiness level

This technology is currently at Technology Readiness Level 5, indicating that it has been validated in relevant environments with preclinical studies underway. Future validation will focus on optimizing safety, efficacy, and reversibility of BBB modulation.